Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology Club of the French Society of Neurosurgery

This publication has 74 references indexed in Scilit:

• Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
  Journal of Clinical Oncology, 2013
• Impact of extent of resection for recurrent glioblastoma on overall survival
  Journal of Neurosurgery, 2012
• First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
  Neurosurgical Review, 2010
• A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
  Journal of Neuro-Oncology, 2010
• Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
  Journal of Clinical Oncology, 2010
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
  The Lancet Oncology, 2009
• Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
  Journal of Neurosurgery, 2009
• Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
  Cancer Chemotherapy and Pharmacology, 2009
• Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
  Journal of Clinical Oncology, 2007
• Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
  New England Journal of Medicine, 2005